| A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ... New England Journal of Medicine 354 (23), 2419-2430, 2006 | 1182 | 2006 |
| The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with … R Forstpointner, M Dreyling, R Repp, S Hermann, A Hänel, B Metzner, ... Blood 104 (10), 3064-3071, 2004 | 748 | 2004 |
| Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia M Brüggemann, T Raff, T Flohr, N Gökbuget, M Nakao, J Droese, ... Blood 107 (3), 1116-1123, 2006 | 654 | 2006 |
| Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German … P Koch, F del Valle, WE Berdel, NA Willich, B Reers, W Hiddemann, ... Journal of clinical oncology 19 (18), 3861-3873, 2001 | 643 | 2001 |
| Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective … A Pastore, V Jurinovic, R Kridel, E Hoster, AM Staiger, M Szczepanowski, ... The lancet oncology 16 (9), 1111-1122, 2015 | 632 | 2015 |
| Treatment of older patients with mantle-cell lymphoma HC Kluin-Nelemans, E Hoster, O Hermine, J Walewski, M Trneny, ... New England Journal of Medicine 367 (6), 520-531, 2012 | 628 | 2012 |
| Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide … R Forstpointner, M Unterhalt, M Dreyling, HP Böck, R Repp, H Wandt, ... Blood 108 (13), 4003-4008, 2006 | 553 | 2006 |
| Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing Nature genetics 44 (12), 1316-1320, 2012 | 482 | 2012 |
| Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger … O Hermine, E Hoster, J Walewski, A Bosly, S Stilgenbauer, C Thieblemont, ... The Lancet 388 (10044), 565-575, 2016 | 441 | 2016 |
| Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma CS Tam, MA Anderson, C Pott, R Agarwal, S Handunnetti, RJ Hicks, ... New England journal of medicine 378 (13), 1211-1223, 2018 | 413 | 2018 |
| Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 PAS Evans, C Pott, P Groenen, G Salles, F Davi, F Berger, JF Garcia, ... Leukemia 21 (2), 207-214, 2007 | 355 | 2007 |
| Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders M Ladetto, M Brüggemann, L Monitillo, S Ferrero, F Pepin, D Drandi, ... Leukemia 28 (6), 1299-1307, 2014 | 343 | 2014 |
| Improved reliability of lymphoma diagnostics via PCR-based clonality testing:—Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 J Van Krieken, AW Langerak, EA Macintyre, M Kneba, E Hodges, ... Leukemia 21 (2), 201-206, 2007 | 331 | 2007 |
| Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma—results of the … P Koch, F del Valle, WE Berdel, NA Willich, B Reers, W Hiddemann, ... Journal of clinical oncology 19 (18), 3874-3883, 2001 | 313 | 2001 |
| Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study C Pott, E Hoster, MH Delfau-Larue, K Beldjord, S Böttcher, V Asnafi, ... Blood, The Journal of the American Society of Hematology 115 (16), 3215-3223, 2010 | 307 | 2010 |
| Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults I Salaverria, C Philipp, I Oschlies, CW Kohler, M Kreuz, M Szczepanowski, ... Blood, The Journal of the American Society of Hematology 118 (1), 139-147, 2011 | 285 | 2011 |
| Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features A Navarro, G Clot, C Royo, P Jares, A Hadzidimitriou, A Agathangelidis, ... Cancer research 72 (20), 5307-5316, 2012 | 283 | 2012 |
| Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a … M Brüggemann, M Kotrova, H Knecht, J Bartram, M Boudjogrha, V Bystry, ... Leukemia 33 (9), 2241-2253, 2019 | 216 | 2019 |
| Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases A Hadzidimitriou, A Agathangelidis, N Darzentas, F Murray, ... Blood, The Journal of the American Society of Hematology 118 (11), 3088-3095, 2011 | 209 | 2011 |
| Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma SM Aukema, M Kreuz, CW Kohler, M Rosolowski, D Hasenclever, ... haematologica 99 (4), 726, 2014 | 204 | 2014 |
